Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity

Journal of Cellular and Molecular Medicine

Volumn 13, Issue 9 B, 2009, Pages 3868-3875

  Ha, Seon Ah ^a   Shin, Seung Min ^a   Kim, Hyun Kee ^a   Kim, Sanghee ^a   Namkoong, Hong ^a   Lee, Youn Soo ^a   Kim, Hae Joo ^a   Jung, Sang Min ^a   Lee, Yu Sun ^a   Chung, Yeun Jun ^a   Park, Yong Gyu ^a   Jung, Sang Seol ^a   Kim, Jin Woo ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Apolipoprotein E; Breast cancer; HCCR 1 oncogene; Obesity

Indexed keywords

APOLIPOPROTEIN E; CELL SURFACE RECEPTOR; HCCR1 PROTEIN, MOUSE; LETMD1 PROTEIN, HUMAN; ONCOPROTEIN;

ANIMAL; ARTICLE; BREAST TUMOR; CELL STRAIN COS1; CERCOPITHECUS; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; METHODOLOGY; MOUSE; OBESITY; TRANSGENIC MOUSE; TUMOR CELL LINE;

ANIMALS; APOLIPOPROTEINS E; BREAST NEOPLASMS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, TRANSGENIC; MICROSCOPY, FLUORESCENCE; OBESITY; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE;

MUS; MUS MUSCULUS;

EID: 77449153137     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2009.00652.x     Document Type: Article

References (23)

1. Ko J, Lee YH, Hwang SY. Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. Oncogene. 2003, 22:4679-89.
2. Jung SS, Park HS, Lee IJ. The HCCR oncoprotein as a biomarker for human breast cancer. Clin Can Res. 2005, 11:7700-8.
3. Lamerz R, Stieber P, Fateh-Moghadam A. Serum marker combinations in human breast cancer (review). In Vivo. 1993, 7:607-14.
4. Cho GW, Shin SM, Namkoong H. The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression. Gene. 2006, 384:18-26.
5. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988, 240:622-30.
6. Browning PJ, Roberts DD, Zabrenetzky V. Apolipoprotein E (ApoE), a novel heparin-binding protein inhibits the development of Kaposi's sarcoma-like lesions in BALB/c nu/nu mice. J Exp Med. 1994, 180:1949-54.
7. Vogel T, Guo NH, Guy R. Apolipoprotein E: a potent inhibitor of endothelial and tumor cell proliferation. J Cell Biochem. 1994, 54:299-308.
8. Huang Z, Hankinson SE, Colditz GA. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997, 278:1407-11.
9. van den Brandt PA, Spiegelman D, Yaun SS. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000, 152:514-27.
10. Lahmann PH, Hoffmann K, Allen N. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer. 2004, 111:762-71.
11. Lorincz AM, Sukumar S. Molecular links between obesity and breast cancer. Endocr Relat Cancer. 2006, 13:279-92.
12. van Landeghem AA, Poortman J, Nabuurs M. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res. 1985, 45:2900-6.
13. Goodwin PJ, Ennis M, Pritchard KI. Fasting insulin and outcome in early stage breast cancer: results of a prospective cohort study. J Clin Oncol. 2002, 20:42-51.
14. Dizdar O, Alyamac E. Obesity: an endocrine tumor. Med Hypotheses. 2004, 63:790-2.
15. Gordon JW, Ruddle FH. Gene transfer into mouse embryos: production of transgenic mice by pronuclear injection. Methods Enzymol. 1983, 101:411-33.
16. Vatten LJ, Foss OP. Total serum cholesterol and triglycerides and risk of breast cancer: a prospective study of 24,329 Norwegian women. Cancer Res. 1990, 50:2341-6.
17. Kumar K, Sachdanandam P, Arivazhagan R. Studies on the changes in plasma lipids and lipoproteins in patients with benign and malignant breast cancer. Biochemistry. 1991, 23:581-9.
18. Agurs-Collins T, Kim KS, Dunston GM. Plasma lipid alterations in African-American women with breast cancer. J Cancer Res Clin Oncol. 1998, 124:186-90.
19. Chlebowski RT, Chen Z, Anderson G. Ethnicity and breast cancer in the Women's Health Initiative: a unifying concept for unfavorable outcome in African American women. Proc Am Soc Clin Oncol. 2004, 23:99s.
20. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002, 20:1128-43.
21. Key TJ, Appleby PN, Reeves GK. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003, 95:1218-26.
22. Enger SM, Greif JM, Polikoff J. Body weight correlates with mortality in early stage breast cancer. Arch Surg. 2004, 139:954-60.
23. Chlebowski RT. Obesity and early-stage breast cancer. J Clin Oncol. 2005, 23:1345-7.